Category: Business

Stanford University Lands NIH Grant to Fund U.S. Phase II Trial of tiakis Biotech’s Elafin (Tiprelestat) in Pulmonary Arterial Hypertension

– Presenting a new, disease-modifying therapeutic approach for Pulmonary Arterial Hypertension (PAH), a rare disease with substantial unmet medical requirements Kiel, GERMANY, September 8, 2025 – tiakis Biotech, a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for severe pulmonary

More

Junshi Biosciences’ JS005 (IL-17A) Phase 3 Study for Moderate to Severe Plaque Psoriasis Achieves Primary Endpoints

SHANGHAI, Sept. 07, 2025 — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a prominent innovation-driven biopharmaceutical firm committed to discovering, developing, and commercializing novel treatments, announced that its recombinant humanized anti-IL-17A monoclonal antibody product (code: JS005)

More